News Conference News ISC 2026 CHOICE-2 Bolsters Intra-arterial Lytics After Stroke Thrombectomy Todd Neale February 06, 2026
News Daily News High Adolescent BP Tied to Subclinical Disease in Middle Age Michael O'Riordan November 20, 2025
News Daily News Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned Yael L. Maxwell November 13, 2025
News Conference News AHA 2025 Beta-blockers Not Helpful After MI in Patients With Preserved EF Yael L. Maxwell November 12, 2025
News Opinion Editor's Corner ESC 2025 What’s Going to Be Hot at ESC Congress 2025? Michael O'Riordan August 25, 2025
News Conference News NY Valves 2025 MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed Yael L. Maxwell July 03, 2025
News Conference News EHRA 2025 Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes Todd Neale April 08, 2025
News Daily News Coverage and Use of Impella and Watchman: A Tale of Four Countries Michael O'Riordan March 04, 2025
News Daily News GLP-1 Drugs in Diabetes Don’t Raise Suicidality Risk, New Data Confirm Caitlin E. Cox February 26, 2025
News Conference News AHA 2024 Spironolactone No Help for the Heart After Acute MI: CLEAR SYNERGY Shelley Wood November 17, 2024
News Conference News VIVA 2024 It’s Been 1 Year Since Medicare’s NCD for Carotid Stenting: What Now? L.A. McKeown November 14, 2024
News Conference News TCT 2024 Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows Michael O'Riordan October 29, 2024
News Conference News ESC 2024 RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board Shelley Wood August 31, 2024
News Daily News Early, Intense GDMT Improves Decongestion in Acute HF: STRONG-HF Todd Neale July 19, 2024
News Daily News Industry Payments Made to Cardiology Fellows Prompt Bias Concerns Yael L. Maxwell July 16, 2024
News Conference News ACC 2024 Coronary Sinus Reducer Eases Symptoms in Refractory Angina: ORBITA-COSMIC Michael O'Riordan April 08, 2024
News Daily News Physicians (Mostly) Negative on Private Equity in Healthcare Michael O'Riordan March 13, 2024